comparemela.com

Latest Breaking News On - Novartis india limited - Page 1 : comparemela.com

Ranjit Shahani, pharma veteran and former VC, MD of Novartis India, passes away

Ranjit Shahani, pharma veteran and former VC, MD of Novartis India, passes away
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.

Switzerland
India
United-kingdom
United-states
Mumbai
Maharashtra
Kanpur
Uttar-pradesh
American
Swiss
Ranjit-shahani
Asia-pacific

Who was Ranjit Shahani: A titan in India's pharmaceutical, business landscape

Ranjit Shahani, was an influential figure in Indian pharma,and former President of OPPI. With a mechanical engineering degree from IIT Kanpur and an MBA from JBIMS Bombay, Shahani held notable positions at ICI and Roche Products before joining Novartis in 1997.

India
Switzerland
United-states
United-kingdom
America
Swiss
Aurobindo-pharma
Asia-pacific
Ranjit-shahani
Roche-products
Novartis-india-ltd
Novartis-india

Former Vice Chairman of Novartis India Ranjit Shahani passes away

Ranjit Shahani, former Vice Chairman and Managing Director of Novartis India and Chairman of JB Pharmaceuticals, has passed away.

United-states
Mumbai
Maharashtra
India
Kanpur
Uttar-pradesh
Switzerland
Swiss
America
Asia-pacific
Ranjit-shahani
Shahani-linkedin

Fierce Pharma Asia—Daiichi's €1B expansion; Astellas' $800M cell-therapy bet; Novartis India's strategic review

Fierce Pharma Asia—Daiichi's €1B expansion; Astellas' $800M cell-therapy bet; Novartis India's strategic review
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Munich
Bayern
Germany
India
China
German
Daiichi-sankyo
Novartis
Astrazeneca
Novartis-healthcare-private
Novartis-india
Novartis-india-limited

Pharma MNCs: Why are pharma MNCs reducing India footprint? - A Deep Dive Analysis | India News

India News: Discover the reasons why pharma MNCs like Novartis, AstraZeneca, Pfizer, Sanofi, and GSK are reducing their footprint in India. Learn about the challenges they face, the transition from manufacturing to licensing and marketing agreements, and the impact on the Indian pharma industry.

India
Switzerland
United-kingdom
Swiss
Astrazeneca
Novartis-india
Novartis
Novartis-india-limited
Ndia-news
Ndia-news-today
Oday-news

vimarsana © 2020. All Rights Reserved.